Pfizer Rises on Good News from India

Pfizer rose 1.4% yesterday to $47.38 per share. As reported by Reuters: "BENGALURU, Nov 11 - Pfizer Ltd ( PFIZ.NS ) , the Indian arm of U.S. pharma giant Pfizer Inc ( PFE.N ) , reported a rise in second-quarter profit on Friday, boosted by price hikes and lower input costs." You can read more about it here. For those of you thinking about investing in the stock, here is a brief look at the company's fundamentals.

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. The company belongs to the Healthcare sector, which has an average price to earnings (P/E) ratio of 13.21 and an average price to book (P/B) ratio of 4.07. In contrast, Pfizer has a trailing 12 month P/E ratio of 9.0 and a P/B ratio of 3.0.

Pfizer has moved -4.7% over the last year compared to -15.5% for the S&P 500 -- a difference of 10.8%. Pfizer has a 52 week high of $61.71 and a 52 week low of $41.45. If you are interested in keeping up to date with equity markets, subscribe to our free newsletter today!

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.